Optimizing the in vitro and clinical assessment of drug interaction risk by understanding co-medications in patient populations.
about
Evaluation of drug-drug interactions for oncology therapies: in vitro-in vivo extrapolation model-based risk assessment.Mechanistic in vitro studies confirm that inhibition of the renal apical efflux transporter multidrug and toxin extrusion (MATE) 1, and not altered absorption, underlies the increased metformin exposure observed in clinical interactions with cimetidRole of Hepatic Drug Transporters in Drug Development.
P2860
Optimizing the in vitro and clinical assessment of drug interaction risk by understanding co-medications in patient populations.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Optimizing the in vitro and cl ...... ations in patient populations.
@en
type
label
Optimizing the in vitro and cl ...... ations in patient populations.
@en
prefLabel
Optimizing the in vitro and cl ...... ations in patient populations.
@en
P2093
P2860
P1476
Optimizing the in vitro and cl ...... cations in patient populations
@en
P2093
Etienne Dumont
Geo Derimanov
Harma Ellens
Jackie Bloomer
P2860
P304
P356
10.1517/17425255.2013.781582
P407
P577
2013-04-16T00:00:00Z